Coenzyme Q10 (CoQ10) has gained attention as a potential supplement for improving egg quality in women trying to conceive, particularly those of advanced maternal age. This naturally occurring antioxidant plays a vital role in cellular energy production and protecting cells from oxidative damage—processes that are crucial for healthy egg development. As women age, both CoQ10 levels and egg quality decline, leading to interest in whether supplementation might help restore mitochondrial function in ageing oocytes. Whilst some small studies suggest potential benefits for fertility outcomes, the evidence remains limited and CoQ10 is not currently recommended in UK fertility guidelines. This article examines the science behind CoQ10 and egg quality, the current evidence base, and important safety considerations.

What Is CoQ10 and How Does It Work in the Body?

Coenzyme Q10 (CoQ10), also known as ubiquinone, is a naturally occurring antioxidant compound found in virtually every cell of the human body. It plays a crucial role in cellular energy production within the mitochondria—the powerhouses of cells—where it facilitates the conversion of nutrients into adenosine triphosphate (ATP), the primary energy currency used by cells to perform their functions.

CoQ10 exists in two main forms: ubiquinone (the oxidised form) and ubiquinol (the reduced, active antioxidant form). The body can convert between these forms as needed. Beyond energy production, CoQ10 serves as a potent antioxidant, protecting cells from oxidative damage caused by free radicals—unstable molecules that can harm cellular structures, including DNA, proteins, and lipids.

Naturally, CoQ10 is synthesised by the body and obtained through dietary sources such as oily fish (salmon, mackerel), organ meats (liver, kidney), whole grains, and certain nuts and seeds. However, endogenous production of CoQ10 generally declines with age. This age-related decline has prompted interest in CoQ10 supplementation, particularly in contexts where cellular energy demands are high or oxidative stress is elevated.

In reproductive health, the mitochondria-rich environment of developing egg cells (oocytes) makes them particularly dependent on adequate CoQ10 levels. As women age, both the quantity and quality of eggs decline, partly due to increased oxidative stress and reduced mitochondrial function—processes that CoQ10 supplementation may theoretically address.

It's important to note that in the UK, CoQ10 is typically sold as a food supplement rather than a licensed medicine, and is not currently recommended in NICE or RCOG guidelines for fertility treatment.

The Link Between CoQ10 and Egg Quality

Egg quality is a critical determinant of female fertility, influencing the likelihood of successful fertilisation, embryo development, and ultimately pregnancy. As women age, particularly after 35 years, egg quality naturally declines due to several interconnected factors, including chromosomal abnormalities (aneuploidy), reduced mitochondrial function, and increased oxidative stress within oocytes.

Mitochondria are exceptionally abundant in egg cells, reflecting the enormous energy requirements for fertilisation, early embryonic division, and implantation. Mitochondrial dysfunction in ageing oocytes leads to insufficient ATP production, which can impair the complex processes of meiosis (the specialised cell division in egg formation) and increase the risk of chromosomal errors.

Oxidative stress—an imbalance between free radical production and antioxidant defences—further compounds age-related egg quality decline. Reactive oxygen species (ROS) can damage mitochondrial DNA, proteins, and membranes within oocytes, creating a vicious cycle of declining cellular function. This is where CoQ10's dual role becomes relevant: as a component of the mitochondrial electron transport chain, it supports energy production, whilst as an antioxidant, it neutralises harmful free radicals.

The theoretical basis for CoQ10 supplementation in fertility rests on the premise that restoring CoQ10 levels in ageing oocytes might improve mitochondrial function, reduce oxidative damage, and thereby enhance egg quality. It's important to understand that 'egg quality' is not directly measurable in routine clinical care but is inferred from surrogate markers such as embryo morphology or aneuploidy rates.

Animal studies have demonstrated that CoQ10 supplementation can improve oocyte quality, increase ovarian reserve markers, and reduce age-related chromosomal abnormalities in older mice, providing biological plausibility for similar effects in humans. However, it should be noted that animal data may not necessarily translate into improved clinical outcomes in humans.

Evidence for CoQ10 Supplementation in Fertility

The clinical evidence supporting CoQ10 supplementation for improving egg quality and fertility outcomes in women remains limited but emerging. Several small-scale human studies and observational data suggest potential benefits, though large, definitive randomised controlled trials are still lacking.

Some studies examining women undergoing in vitro fertilisation (IVF) have found that those who supplemented with CoQ10 (typically 600 mg daily) for two months prior to treatment showed improvements in surrogate markers such as ovarian response to stimulation and embryo quality compared to controls. Research has also explored CoQ10's effects on ovarian reserve markers, particularly anti-Müllerian hormone (AMH) and antral follicle count (AFC), with inconsistent results across trials.

Importantly, while these studies show some promising effects on intermediate outcomes, there is currently no robust evidence demonstrating improved live birth or pregnancy rates with CoQ10 supplementation. This is a crucial distinction, as improvements in surrogate markers do not necessarily translate to the clinical outcomes that matter most to patients.

It is important to note that the evidence base remains insufficient to make definitive clinical recommendations. The Royal College of Obstetricians and Gynaecologists (RCOG) and the National Institute for Health and Care Excellence (NICE) do not currently include CoQ10 in formal fertility treatment guidelines. The Human Fertilisation and Embryology Authority (HFEA) classifies many fertility add-ons, including supplements, according to the strength of supporting evidence.

Most existing studies involve small sample sizes, varying dosages, and different patient populations, making it difficult to draw firm conclusions. Systematic reviews and meta-analyses of available evidence suggest the need for larger, well-designed trials.

Patients considering CoQ10 for fertility purposes should discuss this with their GP or fertility specialist, particularly if undergoing assisted reproductive treatments, to ensure it complements rather than conflicts with their overall management plan.

Recommended Dosage and How to Take CoQ10

There is no universally established dosage of CoQ10 specifically for improving egg quality, as clinical guidelines have not yet incorporated this indication. However, small clinical studies have typically used doses ranging from 200 mg to 600 mg daily, often divided into two or three doses taken with meals. Patients should not exceed the recommended dose on product labels without consulting a healthcare professional.

CoQ10 is a fat-soluble compound, meaning it is best absorbed when taken with food containing some dietary fat. Taking supplements alongside meals that include sources such as avocado, nuts, olive oil, or oily fish can enhance bioavailability. Some formulations use ubiquinol (the reduced form) rather than ubiquinone, with some evidence suggesting potentially better absorption, though clinical superiority remains unproven.

When considering supplementation for fertility purposes, some practitioners recommend beginning at least three months prior to conception attempts or fertility treatment. This timeframe aligns with the approximately 90-day maturation cycle of oocytes (folliculogenesis). However, it's important to note that while this timing is biologically plausible, there is no definitive evidence that this approach improves clinical outcomes.

Key practical considerations include:

• Choose reputable brands that comply with UK regulatory standards

• Start with a moderate dose and adjust based on professional guidance

• Maintain consistency—take supplements at the same time each day

• Store in a cool, dry place away from direct sunlight to preserve potency

Patients should consult their GP or fertility specialist before starting CoQ10, particularly if taking other medications or supplements, to ensure appropriate dosing and avoid potential interactions. Self-prescribing without professional guidance is not advisable, especially in the context of fertility treatment.

Potential Side Effects and Safety Considerations

CoQ10 is generally considered safe and well-tolerated when taken at recommended doses, with a favourable safety profile established through decades of use in various clinical contexts, including cardiovascular health. Most people experience no adverse effects, though mild side effects can occasionally occur.

Potential side effects may include:

• Gastrointestinal disturbances: nausea, diarrhoea, stomach upset, or loss of appetite

• Headaches or dizziness

• Insomnia or sleep disturbances, particularly if taken late in the day

• Skin rashes or itching (rare)

These effects are typically mild and often resolve with continued use or by taking the supplement with food. Dividing the daily dose into smaller amounts taken throughout the day can also minimise gastrointestinal symptoms.

Important safety considerations include:

Drug interactions: CoQ10 may interact with certain medications, particularly warfarin and other anticoagulants, potentially reducing their effectiveness by lowering INR (International Normalised Ratio). Patients taking warfarin should avoid starting CoQ10 without consulting their anticoagulation clinic or GP, and should have their INR monitored if CoQ10 is used. CoQ10 may also interact with some blood pressure medications, chemotherapy drugs, and diabetes treatments. Always inform your GP and pharmacist about all supplements you are taking.

Pregnancy and breastfeeding: Data on safety during pregnancy and lactation remain limited. Women who become pregnant whilst taking CoQ10 should discuss continuation with their healthcare provider.

Pre-existing conditions: Individuals with diabetes should monitor blood glucose levels, as CoQ10 may affect glycaemic control. Those with liver or kidney disease should seek medical advice before supplementation.

If you experience persistent or severe side effects, discontinue use and contact your GP. Seek urgent medical attention if you develop signs of an allergic reaction, such as difficulty breathing, severe rash, or facial swelling.

Report suspected adverse reactions to the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk or via the Yellow Card app).

Other Factors That Influence Egg Quality

Whilst CoQ10 supplementation may offer potential benefits, it is essential to recognise that egg quality is influenced by multiple interconnected factors, many of which are modifiable through lifestyle interventions. A holistic approach to reproductive health addresses these broader determinants alongside any supplementation strategy.

Age remains the single most significant factor affecting egg quality, with a marked decline typically beginning in the mid-thirties and accelerating after 37–38 years. Whilst this process cannot be reversed, optimising other factors may help maximise the quality of remaining eggs.

Lifestyle factors that significantly impact egg quality include:

• Smoking: Tobacco use accelerates ovarian ageing, depletes egg reserves, and increases oxidative stress. Smoking cessation is one of the most important steps for improving fertility.

• Body weight: Both underweight (BMI <18.5 kg/m²) and obesity (BMI >30 kg/m²) can impair egg quality and ovulation. Achieving a healthy BMI through balanced nutrition and regular physical activity improves reproductive outcomes.

• Alcohol consumption: NHS guidance recommends avoiding alcohol when trying to conceive.

• Diet: A Mediterranean-style diet rich in antioxidants, omega-3 fatty acids, whole grains, and lean proteins supports reproductive health. Adequate intake of folate (400 micrograms daily), vitamin D (10 micrograms daily), and other micronutrients is essential for preconception health.

Environmental and occupational exposures to endocrine-disrupting chemicals, pesticides, and excessive heat may impair egg quality. Minimising exposure where possible is advisable.

Stress management is increasingly recognised as important for fertility, though the mechanisms remain complex. Chronic stress may affect hormonal balance and ovarian function.

Medical conditions such as polycystic ovary syndrome (PCOS), endometriosis, and thyroid disorders can impact egg quality and should be appropriately managed.

If you have concerns about fertility or egg quality, consult your GP for assessment and possible referral to a fertility specialist. NICE recommends that couples who have not conceived after 12 months of regular unprotected intercourse should be offered initial fertility investigations. Earlier referral (after 6 months) is appropriate if the woman is over 35 or if there are known factors that may affect fertility, such as amenorrhoea, oligomenorrhoea, known tubal damage, severe endometriosis, or known male factor fertility issues.

Frequently Asked Questions